by James Nestor · 25 May 2020 · 365pp · 96,573 words
one or the other in our lifetime. To help cope, 13 percent of us over the age of 12 will use antidepressants, most often selective serotonin reuptake inhibitors, also known as SSRIs. These drugs have been lifesavers for millions, especially those with severe depression and other serious conditions. But less than half the patients who
…
, 150–51, 157 Decongest the Nose technique, 224 dental problems, and mouthbreathing, 49–50 depression carbon dioxide therapies and, 176–77 slow breathing and, 83 SSRIs (selective serotonin reuptake inhibitors), 176 vagus nerve stimulation and, 150 DeRose, Luíz Sérgio Álvares, 186, 187, 194–95, 197–201 deviated septum, 118 diaphragm, 61–62, 63 diseases of
…
’s World, 94 sa ta na ma chant, 82 Sanborn, David, 68 schizophrenia, and left nostril breathing, 42 Schroth, Katharina, 56–58 scoliosis, 56–57 selective serotonin reuptake inhibitors (SSRIs), 176 sexual arousal, 145n shallow breathing, 64 Shankar, Sri Sri Ravi, 198–99 Shiva Swarodaya, 40 sildenafil (Viagra), 50 Simonetti, Scott, 225 skull development research
…
of, 30 mouth taping and, 52 mouthbreathing and, 28, 49–50 obstructions in mouth and, 120 percentage of population exhibiting, 32 speech, 15 Spire, 213 SSRIs (selective serotonin reuptake inhibitors), 176 Stanford experiment with author and Olsson, 3–9, 16–18, 19–23, 28–29, 37–38, 79–82, 87–89, 105–7, 139, 206
by David Eagleman · 29 May 2011 · 383pp · 92,837 words
for who you believe yourself to be. If you suffer from clinical depression, you will probably be prescribed a medication known as a selective serotonin reuptake inhibitor (abbreviated as an SSRI)—something such as fluoxetine or sertraline or paroxetine or citalopram. Everything you need to know about how these drugs work is contained in the
by David Nutt · 30 May 2012 · 605pp · 110,673 words
that sends messages round the brain – which helps regulate sleep, appetite, muscle contractions, intestinal movements and mood. (When people have clinical depression, we give them Selective Serotonin Reuptake Inhibitors (SSRIs), which help to increase the level of serotonin available to do its work.) Dopamine, a pleasure hormone, is also released, contributing to the sense of
…
much the benzodiazepines help you. The decision requires the same sort of weighing up of the harms and benefits as with any drug. Antidepressants and SSRIs Selective serotonin reuptake inhibitors (SSRIs) were first developed in the 1970s. They have become the most-commonly prescribed type of antidepressants worldwide in the last two decades. Common drugs of
…
Society, David Nutt et al, Elsevier, 2007 3 they have fewer side effects and almost no abuse potential.• Death and dependence: current controversies over the selective serotonin reuptake inhibitors, David Nutt, Journal of Psychopharmacology 17(4), December 2003 4 developing a new medication now costs about $1 billion• Drugs and the Future: Brain Science
…
and, 1 skunk, 1 skunk, and, 1 voices, hearing, 1 Schofield, Penny, 1 school, drugs and, 1 Scunthorpe Two, 1, 2, 3 secondary smoking, 1 selective serotonin reuptake inhibitors, see SSRIs sentence, no effect on cannabis use, 1, 2 serotonin, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14 ecstasy
by Lawrence B. Afrin M. D., Kendra Neilsen Myles and Kristi Posival · 15 Jan 2016
that could come anywhere close to explaining all that was going on with Dwayne. He was tried, at various times, on antihypertensives (beta blockers), antidepressants (selective serotonin reuptake inhibitors), and anti-epileptic drugs, all to no avail. A benzodiazepine, lorazepam, seemed to limit somewhat the frequency at which his anxiety would escalate into panic
…
long suffered symptoms of major depression and are already taking one drug or another from the class of selective serotonin reuptake inhibitors (SSRIs) that are the front-line drugs for treating depression at present. Addition of antihistamines to SSRIs increases the risk for the life-threatening “serotonin syndrome,” for which the clinician must remain alert; should
…
that it has anti-inflammatory properties. Duloxetine “Doo-lox´-eh-teen.” Known more commonly by its popular U.S. trade name Cymbalta, duloxetine is an “SSRI” (selective serotonin reuptake inhibitor) type of antidepressant. Duodenum Pronounced either as “Doo´-oh-dee´-num” or “Doo-ŏd´-en-um.” Coming after the stomach, the duodenum is the first
…
.” More commonly known by its popular U.S. trade name Paxil, paroxetine is one of many drugs in the class of anti-depressant drugs called selective serotonin reuptake inhibitors, or SSRIs. Many MCAD patients are diagnosed as suffering from depression (either because they truly are suffering from a real “major depressive disorder” as defined in
…
by which MCAD can (fortunately only occasionally) lead to septicemia. Serotonin reuptake inhibitors “Seer´-oh-tōn´-in re-up´-tāk” inhibitors. Also known as selective serotonin reuptake inhibitors, or SSRIs, these very commonly prescribed medications were developed to treat depression and generally have been pretty successful at doing so. It was originally thought that the
by Ben Goldacre · 1 Jan 2012 · 402pp · 129,876 words
is in any sense reassuring. One: Information is withheld from regulators Paroxetine is a commonly used antidepressant, from the class of drugs known as ‘selective serotonin reuptake inhibitors’, or SSRIs. You will hear more about this class of drugs later in this book, but here we will use paroxetine to show how companies have exploited
…
, others will often try to produce their own version of that drug: so there are a great many antidepressants around from the class known as ‘selective serotonin reuptake inhibitors’, or SSRIs, for example. Developing a drug like this is much more of a safe bet. Often these me-too drugs don’t represent a significant
…
is how antidepressant drugs work: depression is caused by low serotonin, so you need drugs which raise the serotonin levels in your brain, like SSRI antidepressants, which are ‘selective serotonin reuptake inhibitors’. But this theory is wrong. The ‘serotonin hypothesis’ for depression, as it is known, was always shaky, and the evidence now is hugely
…
generic drug). PMCPA – Prescriptions Medicines Code of Practice Authority. Publication bias – The phenomenon whereby trials with results regarded as unflattering or uninteresting are left unpublished. SSRI – Selective serotonin reuptake inhibitor. Surrogate outcome – Real-world problems are what we really want to change with medicines: things like death, heart attack or stroke. A surrogate outcome is
…
M, Kromp M, Kaiser T, et al. Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials. BMJ. 2010 Oct 12;341:c4737–c4737. 7 Suntharalingam G, Perry MR, Ward S, Brett SJ, Castello-Cortes A, Brunner MD, et al
by Johann Hari · 1 Jan 2018 · 428pp · 126,013 words
depression—that weird, persistent, misfiring unhappiness that won’t go away. Fortunately, just in time for my adulthood, there was a new generation of drugs—Selective Serotonin Reuptake Inhibitors (SSRIs)—that restore your serotonin to the level of a normal person’s. Depression is a brain disease, he said, and this is the cure. He
…
al., “Efficacy and Effectiveness of Antidepressants: Current Status of Research,” Psychotherapy and Psychosomatics 79 (2010): 267–279, doi: 10.1159/000318293; Yasmina Molero et al., “Selective Serotonin Reuptake Inhibitors and Violent Crime: A Cohort Study,” PLOS Medicine 12 no. 9 (Sept. 2015), doi:10.1371/journal.pmed.1001875; Paul W. Andrews, “Primum non nocere
…
harm than good,” Frontiers in Psychology 3, no. 177 (April 2012), https://doi.org/10.3389/fpsyg.2012.00117; A. D. Domar, “The risks of selective serotonin reuptake inhibitor use in infertile women: a review of the impact on fertility, pregnancy, neonatal health and beyond,” Human Reproduction 28, no. 1 (2013): 160–171; Dheeraj
…
factors in depression, here recurring dream of, here research on baboon status hierarchies, here on stress of low or insecure status, here Schwenke, Regina, here Selective Serotonin Reuptake Inhibitors (SSRIs) and chemical imbalance model of depression, here, here effect of, as short-lived, here side effects of, here tests on effectiveness of, here self/ego
…
See also Bromley-by-Bow Center society, Western rejection of concept, here The Spirit Level (Pickett and Wilkinson), here Sptizer, Eliot, here SSRIs. See Selective Serotonin Reuptake Inhibitors Star-D Trials, of SSRIs, here starvation, effects on body, here status and respect current large differences in, here disconnection from, as cause of depression, here and depression
by M. D. James le Fanu M. D. · 1 Jan 1999 · 564pp · 163,106 words
range of mental illness – psychosis, anxiety, depression, mania, and two types of antidepressants of undoubted efficacy, widely prescribed. Then came Prozac, the first of the SSRIs (selective serotonin reuptake inhibitors), so called because of their ability to increase the level of the neurotransmitter serotonin in the brain, launched in 1989 with the dual advantage of
…
in the United States in 1970, twenty years after Cade’s original description of its effect on Mr W. B.’s mania.8 Antidepressants: Tricyclics, Selective Serotonin Reuptake Inhibitors (SSRIs) and Monoamine Oxidase Inhibitors (MAOIs) The first antidepressant – imipramine – arose directly out of the research programme that had led to the discovery of chlorpromazine. Roland
…
made till 1960, a full five years after Kuhn’s original observations.10 In the 1980s the popularity of the tricyclics was eclipsed by the Selective Serotonin Reuptake Inhibitors or SSRIs such as Prozac (fluoxetine), which had fewer side-effects. Their manner of discovery was, however, exactly the same as that of the tricyclics, having
…
science 215–16, 218–19, 220, 263 scientific progressivism 431–2 screening 148, 333–6, 345, 421–2 Seascale see Sellafield secondary metabolites 265–6 selective serotonin reuptake inhibitors (SSRIs) 476, 508 self-experimentation 204, 205, 506 self-healing ability 27, 35, 37 Sellafield 394, 409, 410 Sellors, Holmes 104 Selye, Hans 32 Semm, Kurt
by Bessel van Der Kolk M. D. · 7 Sep 2015 · 600pp · 174,620 words
test to measure how traumatized people perceive their surroundings. These data gave us an important clue to how this class of drugs (formally known as selective serotonin reuptake inhibitors, or SSRIs) might work. Before taking Prozac these patients’ emotions controlled their reactions. I think of a Dutch patient, for example (not in the Prozac study
…
, 15, 22–23, 27, 29 genetics and, 151–52 schools, see education system Schwartz, Richard, 281, 282, 283, 289, 290, 291, 418n Science, 94–95 selective serotonin reuptake inhibitors (SSRIs), 35, 36 see also Prozac (fluoxetine) Self: disorganized attachment and, 120 in IFS therapy, 224, 283–85, 288, 289, 305 in infants, 113 multiple aspects
by Temple Grandin · 10 Jan 2006 · 291pp · 92,406 words
liability. A double-blind placebocontrolled crossover design. American Journal of Psychiatry, 157: 818–820. Edwards J. G. Anderson L. 1999 Systematic review and guide to selective serotonin reuptake inhibitors. Drugs, 57: 507–533. M. Fankhauser, Karumanchi V., M. German, A. Yates, Karumanchi S. D 1992 A double-blind, placebo-controlled study of the efficacy
…
. Journal of Autism and Developmental Disorders, 20, 2:, 169–176. Whittington C. J. T. Kendall, P. Fonagy, D. Cotrell, A. Cotgrove, E. Bod-dington 2004 Selective serotonin reuptake inhibitors in childhood depression: Systematic review of published versus unpublished data. Lancet, 363: 1341–1345. J. Wild 2005 Adult Suicide Linked to Popular Antidepressant (Paxil). Nature
by Robert M. Sapolsky · 1 May 2017 · 1,261pp · 294,715 words
effects in the synapse. The modern antidepressant of choice, Prozac, does exactly that in serotonin synapses. Thus it is often referred to as an “SSRI”—a selective serotonin reuptake inhibitor. Meanwhile, a pharmacopeia of drugs are available to decrease signaling across synapses, and you can see what their underlying mechanisms are going to include—blocking
…
-wing authoritarianism SDO social-dominance orientation SES socioeconomic status SHRP stress hyporesponsive period SNPs single-nucleotide polymorphisms SNS sympathetic nervous system SPE Stanford Prison Experiment SSRI selective serotonin reuptake inhibitor STG superior temporal gyrus TF transcription factor TH tryptophan hydroxylase ToM Theory of Mind TPJ temporoparietal juncture TRC truth and reconciliation commission vlPFC ventrolateral prefrontal
…
, 607 Schultz, Wolfram, 68, 71 Science, 133, 246–47, 251, 266, 278, 300n, 313, 322, 495, 524, 546, 549, 574–75, 636 Scientific American, 298 selective serotonin reuptake inhibitors, 694 self-confidence, 102–3, 237 Semai, 313, 502n Semang, 317, 318 sensorimotor contagion, 86, 395, 522 sensory stimuli, 6–7, 15, 81–98 amygdala
…
11 attacks, 619 Seromba, Athanase, 572 serotonin, 134, 692 aggression and, 76–77, 250–55 genes and, 227, 246, 250–55, 264 psilocybin and, 693 selective serotonin reuptake inhibitors, 694 SES, see socioeconomic status sex, 11, 39, 43, 65–66, 95 oxytocin and, 110 sex differences, 266 cultural, 272 dimorphic, 366 and hormones in
by James Lee · 10 Feb 2014 · 61pp · 16,429 words
by Rita Baron-Faust and Jill Buyon · 21 Apr 2003 · 427pp · 30,920 words
by Mache Seibel · 18 Sep 2017 · 290pp · 86,718 words
by Olivier Ameisen · 23 Dec 2008 · 312pp · 89,728 words
by Timothy Ferriss · 1 Dec 2010 · 836pp · 158,284 words
by Christopher M. Palmer Md · 15 Nov 2022 · 402pp · 107,908 words
by Lara Briden · 14 Apr 2021
by Judith Grisel · 15 Feb 2019 · 213pp · 68,363 words
by Brian Hare and Vanessa Woods · 13 Jul 2020
by Francis Fukuyama · 1 Jan 2002 · 350pp · 96,803 words
by William Davies · 11 May 2015 · 317pp · 87,566 words
by Jerome Bubrick · 31 Dec 2010 · 159pp · 49,513 words
by James Fallon · 30 Oct 2013
by Mary J. Shomon · 31 Aug 2004 · 384pp · 90,089 words
by Linsey McGoey · 14 Sep 2019
by Kathleen DesMaisons, Ph. D. · 265pp · 75,669 words
by Gabor Mate and Peter A. Levine · 5 Jan 2010 · 504pp · 147,660 words
by Susan Senator · 4 Apr 2016 · 298pp · 93,083 words
by Ray Kurzweil · 25 Jun 2024
by Jonathan Haidt · 26 Dec 2005 · 405pp · 130,840 words
by David Tolin, Randy O. Frost and Gail Steketee · 14 Dec 2013 · 223pp · 58,139 words
by Alec Ross · 2 Feb 2016 · 364pp · 99,897 words
by Elaine N. Aron · 1 Dec 2013 · 323pp · 94,683 words
by Nicole Lepera · 9 Mar 2021
by David Nutt · 9 Jan 2020
by Steven Kotler and Jamie Wheal · 21 Feb 2017 · 407pp · 90,238 words
by Lanius, Ruth A.; Vermetten, Eric; Pain, Clare · 11 Jan 2011
by Richard Wrangham · 29 Jan 2019 · 473pp · 130,141 words
by John Moe · 4 May 2020 · 264pp · 89,323 words
by Rosie Wilby · 26 May 2021 · 227pp · 67,264 words
by David Perlmutter and Kristin Loberg · 17 Sep 2013
by Jia Tolentino · 5 Aug 2019 · 305pp · 101,743 words
by Randy Frost · 13 Feb 2013 · 210pp · 64,632 words
by Alexandra Robbins · 31 Mar 2009 · 509pp · 147,998 words
by Simon McCarthy-Jones · 12 Apr 2021
by Michael Ian Black · 28 Feb 2012 · 204pp · 63,571 words
by Linsey McGoey · 14 Apr 2015 · 324pp · 93,606 words
by Ray Kurzweil · 13 Nov 2012 · 372pp · 101,174 words
by Francis Fukuyama · 11 Apr 2011 · 740pp · 217,139 words
by Michael A. Tompkins and Tamara L. Hartl · 31 Mar 2007 · 183pp · 59,353 words
by Brett King · 5 May 2016 · 385pp · 111,113 words
by David William Plummer · 14 Sep 2021
by Aja Raden · 10 May 2021 · 291pp · 85,822 words
by James. Davies · 15 Nov 2021 · 307pp · 88,085 words
by Maya Dusenbery · 6 Mar 2018 · 504pp · 147,722 words
by David G. Blanchflower · 12 Apr 2021 · 566pp · 160,453 words
by Catherine Shanahan M. D. · 2 Jan 2017 · 659pp · 190,874 words
by Andrea L. Glenn and Adrian Raine · 7 Mar 2014
by Susan Cain · 24 Jan 2012 · 377pp · 115,122 words
by Anna Lembke · 24 Aug 2021
by Bruce C. Greenwald · 31 Aug 2016 · 482pp · 125,973 words
by Diane Coyle · 21 Feb 2011 · 523pp · 111,615 words
by Temple Grandin and Richard Panek · 15 Feb 2013
by Kristen R. Ghodsee · 20 Nov 2018 · 211pp · 57,759 words
by Henry Marsh · 3 May 2017 · 257pp · 84,498 words
by Ben Goldacre · 1 Jan 2008 · 322pp · 107,576 words
by Ben Lynch Nd. · 30 Jan 2018 · 438pp · 103,983 words
by Nessa Carey · 31 Aug 2011 · 357pp · 98,854 words
by Michael Pollan · 30 Apr 2018 · 547pp · 148,732 words
by Ben Goldacre · 22 Oct 2014 · 467pp · 116,094 words
by Annabelle Gurwitch · 31 Aug 2010 · 237pp · 82,266 words
by John Brisson · 12 Apr 2014
by Bruce H. Lipton · 1 Jan 2005 · 220pp · 66,518 words
by John Abramson · 20 Sep 2004 · 436pp · 123,488 words
by Jonathan Hobbs · 5 Apr 2017 · 94pp · 18,728 words
by Matthew Tinsley and Sarah Hendrickx · 31 May 2008 · 147pp · 6,471 words
by Melissa Broder · 15 Mar 2016 · 140pp · 47,093 words
by Mike Power · 1 May 2013 · 378pp · 94,468 words
by Paul M. Salkovskis · 8 Sep 2011 · 263pp · 70,706 words
by John Green · 18 Mar 2025 · 158pp · 49,742 words
by Matthew Yglesias · 14 Sep 2020
by Jacqueline Novak · 1 Mar 2016 · 173pp · 54,215 words
by Charles Murray · 28 Jan 2020 · 741pp · 199,502 words
by Johann Hari · 7 May 2024 · 315pp · 98,972 words
by Douglas Coupland · 30 Jun 2011
by Shahida Arabi · 11 Jan 2017
by Steven Kotler · 4 Mar 2014 · 330pp · 88,445 words
by Helen Russell · 14 Sep 2015 · 322pp · 99,918 words
by Hoyt L. Barber · 23 Feb 2012 · 192pp · 72,822 words
by Jonathon Sullivan and Andy Baker · 2 Dec 2016 · 742pp · 166,595 words
by Donna Jackson Nakazawa · 6 Jul 2015 · 435pp · 95,864 words
by Will Storr · 14 Jun 2017 · 431pp · 129,071 words
by Dr. Elizabeth Blackburn and Dr. Elissa Epel · 3 Jan 2017 · 381pp · 111,629 words
by Douglas Rushkoff · 21 Mar 2013 · 323pp · 95,939 words
by New Scientist and Helen Thomson · 7 Jan 2021 · 442pp · 85,640 words
by Daniel Lieberman · 2 Sep 2020 · 687pp · 165,457 words
by Angel Au-Yeung and David Jeans · 25 Apr 2023 · 427pp · 134,098 words
by Lonely Planet
by Brock Bastian · 25 Jan 2018
by Jamieson Webster · 20 Feb 2025 · 198pp · 63,059 words
by Tawny Lara · 19 Sep 2023 · 154pp · 45,857 words